申请人:Ajinomoto Co., Inc.
公开号:EP2937335A1
公开(公告)日:2015-10-28
A compound represented by the formula (I):
wherein each symbol is as defined in the DESCRIPTION, has a TRPA1 antagonist activity, and the compound and a medicament containing the compound are useful for the prophylaxis or treatment of diseases involving TRPA1 antagonist and TRPA1.
式 (I) 所代表的化合物:
其中各符号如描述中定义,具有 TRPA1 拮抗剂活性,且该化合物和含有该化合物的药物可用于预防或治疗涉及 TRPA1 拮抗剂和 TRPA1 的疾病。